Your future self will thank you for taking the time to find products that truly make a difference.
Compliance News | November 11, 2025 The administration, together with pharmaceutical manufacturers Eli Lilly and Novo Nordisk, announced an agreement to lower prices and expand access to glucagon-like peptide-1 receptor agonists (GLP-1s) for weight loss for those in the Medicare Part D and Medicaid programs as well as direct-to-consumer (DTC) purchasing
Sangchart P, Panyatip P, Damrongrungruang T, Priprem A, Mahakunakorn P, Puthongking P
Jin X, Liu T, Xu J et al (2019) Exogenous GABA enhances muskmelon tolerance to salinity-alkalinity stress by regulating redox balance and chlorophyll biosynthesis
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Greta McLaren brings decades of experience in anti-aging and aesthetic medicine to help patients lose weight safely and sustainably